Loading...
XSHG
600721
Market cap434mUSD
Jul 25, Last price  
8.11CNY
1D
0.00%
1Q
18.74%
Jan 2017
-56.30%
Name

Xinjiang Bai Hua Cun Co Ltd

Chart & Performance

D1W1MN
XSHG:600721 chart
No data to show
P/E
75.14
P/S
8.08
EPS
0.11
Div Yield, %
—
Shrs. gr., 5y
-0.85%
Rev. gr., 5y
8.04%
Revenues
386m
+4.46%
46,175,16652,846,48837,562,32039,089,94163,649,936696,564,2511,209,836,8881,118,869,8201,181,709,6961,108,870,132808,805,222744,574,204419,502,543419,189,442262,017,71884,530,414281,353,040349,884,562369,277,391385,755,767
Net income
41m
+219.75%
01,283,0285,630,5316,703,01417,060,94741,038,76575,539,09420,465,3562,991,69700139,134,1570034,384,702059,827,132012,972,33741,479,043
CFO
80m
+26.15%
8,095,0036,480,98411,085,98712,251,0320339,112,920559,640,574342,002,9396,631,614202,160,848423,580,9520080,553,7170034,721,68353,177,02763,645,19280,288,556
Dividend
May 22, 19970.0784 CNY/sh

Profile

Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd engages in the pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses. The company was formerly known as Xinjiang Baihuacun Co., Ltd. and changed its name to Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd in July 2021. Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd was founded in 1959 and is headquartered in Urumqi, China.
URL
http://www.xjbhc.net/
IPO date
Jun 26, 1996
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
385,756
4.46%
369,277
5.54%
349,885
24.36%
Cost of revenue
269,559
272,298
270,761
Unusual Expense (Income)
NOPBT
116,196
96,979
79,124
NOPBT Margin
30.12%
26.26%
22.61%
Operating Taxes
3,509
2,612
Tax Rate
3.62%
3.30%
NOPAT
116,196
93,470
76,512
Net income
41,479
219.75%
12,972
 
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
505
Long-term debt
2,263
3,642
Deferred revenue
1,060
1,810
2,353
Other long-term liabilities
2,261
1,927
1,493
Net debt
(272,048)
(263,510)
(436,994)
Cash flow
Cash from operating activities
80,289
63,645
53,177
CAPEX
(17,239)
Cash from investing activities
(15,653)
Cash from financing activities
11,765
19,913
6,225
FCF
171,340
121,096
142,725
Balance
Cash
272,048
202,071
135,731
Long term investments
1
63,703
305,411
Excess cash
252,760
247,309
423,647
Stockholders' equity
384,033
381,693
446,378
Invested Capital
509,143
464,174
245,858
ROIC
23.88%
26.33%
27.56%
ROCE
14.43%
12.87%
11.16%
EV
Common stock shares outstanding
383,123
379,308
375,729
Price
6.59
-14.86%
7.74
26.06%
6.14
-18.02%
Market cap
2,524,781
-14.00%
2,935,845
27.26%
2,306,979
-17.89%
EV
2,252,733
2,672,334
1,869,984
EBITDA
134,774
122,018
105,282
EV/EBITDA
16.71
21.90
17.76
Interest
60
63
113
Interest/NOPBT
0.05%
0.07%
0.14%